Position in PHVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,360,925
+$3,597,129 QoQ
Shares Held
241,785
+43.4% QoQ
Ownership
0.344%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#39
of 124 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Derivatives in PHVS
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$297,388
PutShares
8,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. PHVS ranks #111 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in PHVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297,388 | 8,600 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $8,360,925 | 241,785 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,763,796 | 168,630 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,748,164 | 135,069 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,236,963 | 129,738 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $514,289 | 29,221 | Shares | Defined | 2025-08-14 | |
| 2024-06-30 | $272,072 | 14,472 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,507,227 | 238,305 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,967,896 | 141,458 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||